Canadian Institutes of Health Research
VC Fund
Canadian Institutes of Health Research is a VC fund focused on Biotechnology and Health Care.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Canadian Institutes of Health Research invests in
Stages Canadian Institutes of Health Research invests in
Countries Canadian Institutes of Health Research invests in
Investment Focus
Industry
- Biotechnology 5 (56%)
- Health Care 4 (44%)
- Health Diagnostics 2 (22%)
- Fitness 1 (11%)
- Medical 1 (11%)
Country
- Canada 7 (78%)
- United States 2 (22%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
BC Children's Hospital Foundation
|
BCCHF is the province's only full-service, pediatric acute care hospital and serves the one million children living in BC and the Yukon. | $750K / Grant / Jul 11, 2024 | |
McGill University
|
McGill University is one of Canada's best-known institutions of higher learning and one of the leading universities in the world. With students coming to McGill from some 150 countries, our student body is the most internationally diverse of any research-intensive university in the country. McGill was founded in 1821 thanks to a generousbequest by James McGill, and since then, we've grown from a small college to a bustling university with two campuses, 11 faculties, some 300 programs of study, and more than 37,500 students. The University also partners with four affiliated teaching hospitals to graduate over 1,000 health care professionals each year.In addition to a stellar faculty, McGill is known for attracting the brightest students from across Canada, the United States, and around the world. McGill students have the highest average entering grades in Canada, and our commitment to fostering the very best has helped our students win more national and international awards on average than their peers at any other Canadian university. The prestigious Rhodes Scholarship has gone to a nation-leading 136 McGill students. | $1.6M / Grant / Jul 03, 2024 | |
BLR Bio
|
BLR Bio is a privately held biotechnology business with a focus on orphan and specialty fibrotic diseases. | $780K / Grant / Feb 14, 2023 | |
Genwell Project
|
Genwell Project was created to solve the problems of social isolation, separation, and loneliness by utilizing the power of human connection. | $761K / Grant / Aug 18, 2022 | |
Arch Biopartners
|
Arch Biopartners Inc., a biotechnology company, focuses on acquiring and developing products and technology for sale to pharmaceutical and industrial companies. The company, through its subsidiaries, focuses on developing diagnosis and treatments for brain tumors; binding of peptides to solid surfaces; treatments for chronic kidney and boweldiseases caused by non-infectious inflammation; and anti-cancer compounds. Arch Biopartners Inc. is headquartered in Toronto, Canada. | $750K / Grant / Jul 14, 2021 | |
BioMark Diagnostics
|
BioMark is an oncology-focused company with advanced near-to- market diagnostic technologies designed to improve patient outcomes. They have developed and own multiple intellectual properties (IPs) in detection and quantitation of metabolites.They hand-picked a proven, global enterprise team of scientists, engineers and medical professionals tohelp commercialize their innovative technology and to increase prediction and accuracy in the diagnosis of cancers by following and incorporating the highest regulatory ,clinical and scientific standards.. Their cross pollinated, balanced and committed team was established in 2007. Their mission is to develop and commercialize innovative technologies to increase prediction and accuracy in diagnosis of cancers. | $683.4K / Grant / Jun 01, 2021 | |
Sepset Biosciences
|
Sepset Biosciences Inc., a CDRD portfolio company, in collaboration with Dr. Robert Hancock and Dr. Olga Pena, at the University of British Columbia, is developing a first in class diagnostic assay for the early and rapid diagnosis of sepsis. This unique diagnostic is based on the detection of a unique signature of sepsis based on the immuneresponse rather than the presences of a pathogen. | Grant / Jul 16, 2020 | |
OncoSenX
|
OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle that selectively kills cancerous cells based on their transcriptional activity, providing cancer patients, doctors and medical care professionals with a less invasive and more preciseintervention for this complex and devastating disease. | $4.2M / Grant / Jul 02, 2020 | |
Fieldetect
|
Fieldetect is commercializing a handheld device that will identify DNA of known pathogens in agriculture. LabAnywhere is an ‘in-the-field’ agricultural and environmental pathogen detection technology, eliminating the need for laboratory analysis, sample tracking and shipment, molecular biology experience, or handling by laboratory technicians. | $355K / Grant / Mar 23, 2020 |
Co-Investors
Canadian Cancer Society
1 deal together
Government Of Quebec
1 deal together
MEDTEQ+
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Canadian Institutes of Health Research invest in?
Canadian Institutes of Health Research invests primarily in Biotechnology, Health Care and Health Diagnostics startups, most often at Grant stage. Most of the 9 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Canadian Institutes of Health Research last invest?
The most recent investment recorded for Canadian Institutes of Health Research closed in Jul 2024. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
